Kanser tedavisinde biyotoksinler

Yaklaşık yarım yüzyıldır antitümör etkinliğe sahip biyolojik ajanlar üzerinde çalışılmaktadır. Antitümör etkinliğe sahip bu ajanlar arasında yılan ve akrep zehirinin çok çeşitli biyolojik özelliklere sahip olduğu gösterilmiştir. Zehir bileşimindeki maddeler, antitümör etkilerini doğrudan sitolitik ve sitotoksik aktiviteleriyle ya da vücudun bağışıklık sistemini güçlendirmek suretiyle dolaylı olarak gösterirler. Sayılan peptid bileşenlerinin veya sentetik analoglarının terapötik amaçlı kullanımlarında, güçlü bir antitümöral etki oluşturmalarının yanında ciddi bir yan etkiye yol açmamaları münasebetiyle yakın gelecekte klasik antineoplastiklerin yerini alacakları ifade edilmektedir.

Biotoxins in cancer therapy

The search for biological antitumor agents has been pursued for over half a century. Among the biological agents which have antitumoral activity, snake and scorpion venoms have been shown to possess a wide spectrum of biological activities. Venom components exhibit an antitumoral activity by means of direct cytolytic and cytostatic effects or indirect mechanisms such as amplifying of immune response against cancerous cells. These peptides constitute a potent antitumoral activity throughout their thrapeutic usages while they cause any significant side effects. Therefore it has been emphasized that natural venom peptides or their synthetic analogues will be valuable agents in replacement of classical antineoplastic drugs in cancer therapy in the future.

___

  • 1. Lipps BV. Novel snake venom proteins cytolytic to cancer cells in vitro and in vivo systems. J. Venom. Anim. Toxins, 1999;5:172-183.
  • 2. da Silva RJ, Fecchio D, Barraviera B. Antitumor effect of snake venoms. J. Venom. Anim. Toxins, 1996; 2:79-90.
  • 3. da Silva RJ, da Silva MG, Vilela LC, Fecchio D. Antitumor effect of Bothrops jararaca venom. Mediators Inflamm. 2002;11:99-104.
  • 4. Snake bites and venoms. http://www.reptileallsorts.com/bitesvenom.htm
  • 5. Mady EA. Antitumor and biochemical effects of Echis coloratus crude venom on Ehrlich ascites carcinoma cells in vivo. J. Venom. Anim. Toxins, 2002; 8:283-296.
  • 6. Markland FS Jr. Antitumor action of crotalase, a defibrinogenating snake venom enzyme. Semin Thromb Hemost. 1986;12:284-290.
  • 7. Lewis RJ, Garcia ML. Therapeutic potential of venom peptides. Nature reviews. Drug discovery., 2003; 2:790-802.
  • http://www.imb.uq.edu.au/download/large/ Venom_therapeutics.pdf
  • 8. Pardo-Lopez L, Zhang M, Liu J, et all.. Mapping the binding site of human ether-a-gogo- related gene-specific peptide toxin (ErgTx) to the channel’s outer vestibule. J. Biol. Chem 2002; 277: 16403-16411.
  • 9. Milnes JT, Dempsey CE, Ridley JM, et all. Preferential closed channel blokade of HERG potassium currents by chemically synthesised BeKm-1 scorpion toxin. FEBS Letters 2003; 547:20-26.
  • 10. Diochot S, Loret E, Bruhn T, Beress L, Lazdunski M. APETx1, a new toxin from the sea anemone Anthopleura elegantissima, blocks voltage-gated human ether-a-go-gorelated gene potassium channels. Mol Pharmacol. 2003; 64:59-69.
  • 11. Stühmer W. The EAG potassium channel as a target for marine toxins. 2002: 14. http://www.venomstodrugs.com/Venoms_Abstract_book.pdf
  • 12. Skarnulis L, Nazario B. Wonder drugs using pharmazooticals. WebMD Inc., 2003 http://www.webmd.com/content/article/78/95687.htm
  • 13. Scorpion venom might help in brain cancer – study. http://naturalhealthline.com/newsletter/HL 990201/venom.htm
  • 14. From bites and stings to medicines. http://www.chemsoc.org/chembytes/ezine/ 1999/berressem_apr99.htm
  • 15. Swenson S, Costa F, Minea R, et all. Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression. Mol Cancer Ther.2004;3:499-511
  • 16. Highfield R. Snake’s venom may help treat breast cancer. http://arachnophiliac.co.uk/burrow/news/snake s_venom_and_breast_cancer.htm